METHYL 2-(HYDROXYMETHYL)ACRYLATE,
15484-46-5,
Methyl 2-(hydroxymethyl)prop-2-enoate,
Methyl2-(Hydroxymethyl)Acrylate,
Methyl-2-(hydroxymethyl)-acrylate,
Methyl 2-(hydroxymethyl)acrylate, 85%, stabilized with 0.1 wt.% MEHQ,
PubChem17373,
SCHEMBL36299,
methyl 2-hydroxymethylacrylate,
CHEMBL1256639,
CTK3J4731,
methyl alpha-hydroxymethylacrylate,
DTXSID20473358,
methyl 2-(hydroxymethyl) acrylate,
RFUCOAQWQVDBEU-UHFFFAOYSA-N,
2-hydroxymethylacrylate methyl ester,
2-methylolacrylic acid methyl ester,
KS-000025YM,
methyl alpha-(hydroxymethyl)acrylate,
ANW-64210,
BBL103874,
CM0097,
MFCD12545894,
STL557684,
ZINC36455542,
AKOS007930334,
GS-3868,
RTR-006456,
METHYL-2-(HYDROXYMETHYL)ACRYLATE,
AJ-92912,
AK-40245,
BR-40245,
DA-17478,
SC-53992,
2-(hydroxymethyl)-acrylic acid methyl ester,
AB0005280,
TR-006456,
AM20120617,
FT-0645850,
ST24030905,
X7006,
10.14272/RFUCOAQWQVDBEU-UHFFFAOYSA-N,
S-1471,
484M465,
doi:10.14272/RFUCOAQWQVDBEU-UHFFFAOYSA-N,
Methyl 2-(hydroxymethyl)acrylate, contain inhibitor,
I14-14055,
Methyl 2-(hydroxymethyl)acrylate contains 500ppm BHT as inhibitor,
23W,
C5H8O3,
CID11815329,
7-CHLORO-3,4-DIHYDRO-1H-BENZO[B]AZEPIN-5(2H)-ONE,